A phase I study of HEC73543, an oral FLT3 inhibitor: the effect of food on pharmacokinetics after oral dosing in healthy Chinese volunteers

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2025-10-08
DOI
https://doi.org/10.3389/fphar.2025.1636504
Citations
2
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
3.25
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A phase I study of HEC73543, an oral FLT3 inhibitor: the effect of food on pharmacokinetics after oral dosing in healthy Chinese volunteers

Li Deng, Bing Liu, Yingzhi Jiang, Min Wu et al.
2 citations
Frontiers in Pharmacology
Chronic Lymphocytic Leukemia Research
3.25
article

A phase I study of HEC73543, an oral FLT3 inhibitor: the effect of food on pharmacokinetics after oral dosing in healthy Chinese volunteers

Li Deng, Bing Liu, Yingzhi Jiang, Min Wu, Lei Wang, Ying‐Jun Zhang, Xiaojiao Li, Yanhua Ding
article en
2 citations

Abstract

No abstract available for this paper.
Frontiers in PharmacologyVol. 16
Jilin University (CN), HEC Pharm (China) (CN), First Hospital of Jilin University (CN)
Openalex Percentile: Top 7%
Chronic Lymphocytic Leukemia Research
3.25
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A phase I study of HEC73543, an oral FLT3 inhibitor: the effect of food on pharmacokinetics after oral dosing in healthy Chinese volunteers — Li Deng, Bing Liu, et al. · Frontiers in Pharmacology (2025) | TGRS Research Map | TGRS